Abstract | BACKGROUND: METHODS: For persons 45-76 years of age, levels of high-sensitivity C-reactive protein ( hsCRP), interleukin (IL)-6, D-dimer, and cystatin C were compared in 494 HIV-infected individuals in the Strategies for Management of Anti-Retroviral Therapy (SMART) study and 5386 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) study. For persons 33-44 years of age, hsCRP and IL-6 levels were compared in 287 participants in the SMART study and 3231 participants in the Coronary Artery Development in Young Adults (CARDIA) study. RESULTS:
hsCRP and IL-6 levels were 55% (P < . 001) and 62 (P < . 001) higher among HIV-infected participants than among CARDIA study participants. Compared with levels noted in MESA study participants, hsCRP, IL-6, D-dimer, and cystatin C levels were 50%, 152%, 94%, and 27% higher, respectively (P < . 001, for each), among HIV-infected participants. HIV-infected participants receiving antiretroviral therapy who had HIV RNA levels 400 copies/mL had levels higher (by 21% to 60%) (P < . 001) than those in the general population, for all biomarkers. CONCLUSIONS:
hsCRP, IL-6, D-dimer, and cystatin C levels are elevated in persons with HIV infection and remain so even after HIV RNA levels are suppressed with antiretroviral therapy. Additional research is needed on the pathophysiology of HIV-induced activation of inflammatory and coagulation pathways, to guide potential interventions.
|
Authors | Jacqueline Neuhaus, David R Jacobs Jr, Jason V Baker, Alexandra Calmy, Daniel Duprez, Alberto La Rosa, Lewis H Kuller, Sarah L Pett, Matti Ristola, Michael J Ross, Michael G Shlipak, Russell Tracy, James D Neaton |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 201
Issue 12
Pg. 1788-95
(Jun 15 2010)
ISSN: 1537-6613 [Electronic] United States |
PMID | 20446848
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Anti-HIV Agents
- Biomarkers
- Cystatin C
- Fibrin Fibrinogen Degradation Products
- Interleukin-6
- fibrin fragment D
- C-Reactive Protein
|
Topics |
- Adult
- Aged
- Anti-HIV Agents
(therapeutic use)
- Biomarkers
- Blood Coagulation Disorders
(pathology)
- C-Reactive Protein
(analysis)
- Cystatin C
(blood)
- Female
- Fibrin Fibrinogen Degradation Products
(analysis)
- HIV Infections
(complications, drug therapy)
- Humans
- Inflammation
(pathology)
- Interleukin-6
(blood)
- Kidney Diseases
(pathology)
- Male
- Middle Aged
- Viral Load
|